Target Levels of Arterial Pressure in Patients with Arterial Hypertension and Stroke
https://doi.org/10.18087/cardio.2019.8.n337
Abstract
Number of patients with arterial hypertension and stroke steadily grows. “Target” levels of arterial pressure are not established in patients after stroke. In this review, we present results of clinical trials and data of meta-analyses on this problem. Problems related to target levels of arterial pressure after stroke are also covered in a framework of present Russian (2010), European (2018) and American (2017) recommendations on diagnosis and treatment of arterial hypertension.
About the Authors
E. A. Lopina
Federal State Budgetary Educational Institution of Higher Education «Orenburg State Medical University» of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Ekaterina Anatolyevna Lopina - Ph.D., Associate Professor of the Hospital Therapy Department
A. G. Dushina
Federal State Budgetary Educational Institution of Higher Education «Orenburg State Medical University» of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Alena Gennadievna Dushina - Ph.D., Associate Professor of the Hospital Therapy Department
R. A. Libis
Federal State Budgetary Educational Institution of Higher Education «Orenburg State Medical University» of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Roman Aronovich Libis - Doctor of Medical Sciences, Professor, Head of the Department of Hospital Therapy
References
1. Chazova I.E., Zhernakova Yu.V., Oschepkova E.V., Shal'nova S.A., Yarovaya E.B., Konradi A.O. et al. Prevalence of Cardiovascular Risk Factors in Russian Population of Patients With Arterial Hypertension. Kardiologiia. 2014;54(10):4-12.
2. . Parfenov V.A., Starchina Yu.A. Cognitive disorders in patients with essential hypertension and their treatment. Neurology, neuropsychiatry, psychosomatics. 2011;1:27-33.
3. Vishram JKK, Borglykke A, Andreasen AH, Jeppesen J, Ibsen H, Jorgensen T et al. Impact of Age on the Importance of Systolic and Diastolic Blood Pressures for Stroke Risk: The MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) Project. Hypertension. 2012;60(5):1117-23. DOI: 10.1161/HYPERTENSIONAHA.112.201400
4. Nedogoda S.V., Sabanov A.V. Achievement of target blood pressure in patients with arterial hypertension on the background of antihypertensive therapy in real clinical practice. Russian Journal of Cardiology. 2018;23(11):100-9. DOI: 10.15829/1560-4071-2018-11-100-109
5. Boytsov S.A., Balanova Yu.A., Shal'nova S.A., Deev A.D., Artamonova G.V., Gatagonova T.M. et al. Arterial hypertension among persons aged 25-64: prevalence, awareness, treatment and control. By the data from ECCD. Cardiovascular Therapy and Prevention. 2014;13(4):4-14. DOI: 10.15829/1728-8800-2014-4-4-14
6. PATS Collaborating Group. Post-stroke antihypertensive treatment study. A preliminary result. Chinese Medical Journal. 1995;108(9):710-7. PMID: 8575241
7. Bangalore S, Messerli FH, Wun C-C, Zuckerman AL, DeMicco D, Kostis JB et al. J-curve revisited: an analysis of blood pressure and cardiovascular events in NT) Trial. European Heart Journal. 2010;31(23):2897-908. DOI: 10.1093/eurheartj/ehq328
8. Zanchetti A. Blood pressure targets of antihypertensive treatment: up and down the J-shaped curve. European Heart Journal. 2010;31(23):2837-40. DOI: 10.1093/eurheartj/ehq281
9. Hansson L, Hedner T, Lund-J ohansen P, Kj eldsen SE, Lindholm LH, Syvertsen JO et al. Randomised trial of effects of calcium antagonists compared with diuretics and p-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. The Lancet. 2000;356(9227):359-65. DOI: 10.1016/S0140-6736(00)02526-5
10. Zanchetti A. Evidence and wisdom: recommendations for forthcoming guidelines: Journal of Hypertension. 2011;29(1):1-3. DOI: 10.1097/HJH.0b013e328341fb35
11. Belenkov Yu.N., Mareev V.Yu. The treatment of congestive heart failure in XXI century: questions and lessons of evidence based medicine. Cardiology. 2008;48(2):6-16.
12. PROGRESS Collaborative Group. Randomised trial of a perindo-pril-based blood-pressure-lowering regimen among 6 105 individuals with previous stroke or transient ischaemic attack. The Lancet. 2001;358(9287):1033-41. DOI: 10.1016/S0140-6736(01)06178-5
13. Chazova I.E., Ratova L.G., Boytsov S.A., Nebieridze D.V., Karpov Yu.A., Belousov Yu.B. et al. Diagnosis and treatment of arterial hypertension (Recommendations of the Russian Medical S ociety on Arterial Hypertension and the All-Russian Scientific Society of Cardiology). Systemic Hypertensions. 2010;3:5-26.
14. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC et al. Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2011;42(1):227-76. DOI: 10.1161/STR.0b013e3181f7d043
15. Denisov I.N., Kandyba D.V., Kuznetsova O.Yu. Diagnostics and tactics at stroke in conditions of general medical practice, including primary and secondary prevention. Clinical recommendations. Kazan. 2013. - 33p.
16. The Dutch TIA Trial Study Group. Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke. Stroke. 1993;24(4):543-8. PMID: 8465360
17. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet (London, England). 2000;355(9200):253-9. PMID: 10675071
18. Rashid P, Leonardi-Bee J, Bath P. Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events: A Systematic Review. Stroke. 2003;34(11):2741-8. DOI: 10.1161/01.STR.0000092488.40085.15
19. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Journal of the American College of Cardiology. 2018;71(19):e127-248. DOI: 10.1016/j.jacc.2017.11.006
20. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. New England Journal of Medicine. 2010;362(17):1575-85. DOI: 10.1056/NEJMoa1001286
21. The SPRINT Research Group. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. New England Journal of Medicine. 2015;373(22):2103-16. DOI: 10.1056/NEJMoa1511939
22. MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. BMJ. 1985;291(6488):97-104. DOI: 10.1136/bmj.291.6488.97
23. Hypertension Detection and Follow-up Program Cooperative Group*. The Effect of Treatment on Mortality in Mild Hypertension: Results of the Hypertension Detection and Follow-up Program. New England Journal of Medicine. 1982;307(16):976-80. DOI: 10.1056/NEJM198210143071603
24. Zhang Y, Zhang X, Liu L, Zanchetti A, for the FEVER Study Group. Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial. European Heart Journal. 2011;32(12):1500-8. DOI: 10.1093/eurheartj/ehr039
25. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. The Lancet. 2016;387(10022):957-67. DOI: 10.1016/S0140-6736(15)01225-8
26. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD et al. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/ American Stroke Association. Stroke. 2014;45(7):2160-236. DOI: 10.1161/STR.0000000000000024
27. Arima H, Chalmers J, Woodward M, Anderson C, Rodgers A, Davis S et al. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial: Journal of Hypertension. 2006;24(6):1201-8. DOI: 10.1097/01.hjh.0000226212.34055.86
Review
For citations:
Lopina E.A., Dushina A.G., Libis R.A. Target Levels of Arterial Pressure in Patients with Arterial Hypertension and Stroke. Kardiologiia. 2019;59(8):72-76. (In Russ.) https://doi.org/10.18087/cardio.2019.8.n337
Views:
2961
Email this article 
Post a Comment 
